Voxelotor Improves Hemoglobin Levels in Sickle Cell Disease
Fewer individuals in voxelotor group versus placebo group have worsened anemia at week 24.
Sickle Cell Disease
Risk Factors for Recurrent Venous Thromboembolism in Patients With Sickle Cell Disease
Patients with severe sickle cell disease were more than twice as likely to experience recurrent thromboembolism compared with patients with less severe disease.
Individualized Management Approach May Improve Care and Cut Costs for Sickle Cell Pain
A multidisciplinary intervention strategy led to a 61% decrease in hospital stay duration for patients with sickle cell disease and vaso-occlusive pain.
New Law Boosts Fight Against Sickle Cell Disease
In 2018, the National Institutes of Health was funded approximately 115 million for research of the disease.
A Novel and Rapid Assay for Sickle Cell Disease Screening
Children born with sickle cell disease in low-resource regions of the world often remain undiagnosed and therefore do not receive appropriate treatment.
L-Glutamine Oral Therapy Reduces Sickle Cell-Related Pain Better Than Placebo
L-Glutamine oral treatment with or without hydroxyurea reduces pain crises better than placebo in individuals with sickle cell disease.
Chronic Pain Leads to Higher Opioid Doses and Lower QoL in Sickle Cell Patients
In adults with sickle cell disease, higher daily opioid use may be associated with poorer health-related quality of life.
Next post in Pain Information Center
